6 November 2017 (Monday) - Treating CLL
Maybe not of immediate relevance to me, but this article from the American Society of Hematology discussed the latest treatments in C.L.L.
Basically the treatment involves giving anti-CD20. CD20 is a B-lymphocyte marker. I can remember this approach being in the realms of science-fiction when I was at college…
Labels: journal review